Participant count type changed
Before: Estimated. After: Actual.
Enrollment · participant count changed
Before: 32 participants (planned). After: 37 participants (actual).
Study sponsor: Ultragenyx Pharmaceutical Inc · RARE
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: Estimated. After: Actual.
Before: 32 participants (planned). After: 37 participants (actual).
Before: Actual. After: Estimated.
Before: 19 Feb 2025. After: Sep 2027.